Shionogi Europe’s Post

View organization page for Shionogi Europe, graphic

12,329 followers

From the United Nations to the G7, antimicrobial resistance (AMR) has rightly been in the global health spotlight at many high-level meetings this year. At Shionogi we continue to focus our efforts on helping to address the urgent crisis of drug-resistant infection, through our scientific research and advocating for sustainable policy solutions. Recently, we worked with Euractiv on a Shionogi-supported special report to highlight some of the challenges we must face together to help tackle AMR - "Antimicrobial resistance fight needs more ambition, new alliances and strategies". We covered these three important areas in the report: • Dr Isao Teshirogi, President & CEO of Shionogi, highlights the urgent need for new antibiotics and the economic challenges in R&D. • Simona Falciai, General Manager of Shionogi Italia, shares insights after the G7 Health Ministers’ meeting, where Italy’s Minister of Health, Professor Orazio Schillaci, pledged to tackle market failures in AMR. • At the #EuropeanHealthSummit, Huw Tippett, CEO of Shionogi Europe, calls for a rethink of antibiotics business models. Find out more in the full Euractiv report here: https://lnkd.in/eh6mBM4B #AMR #GlobalHealth #Innovation  #PublicHealth #G7 #AMRHLM

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics